180 related articles for article (PubMed ID: 2535976)
1. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation?
van Son WJ; van der Bij W; Tegzess AM; Anema J; van der Giessen M; van der Hem GK; Marrink J; The TH
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):109-21. PubMed ID: 2535976
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation.
van Son WJ; Tegzess AM; Hauw The T; Duipmans J; Slooff MJ; van der Mark TW; Peset R
Am Rev Respir Dis; 1987 Sep; 136(3):580-5. PubMed ID: 2820281
[TBL] [Abstract][Full Text] [Related]
3. Complement activation associated with active cytomegalovirus infection in renal transplant patients, and its absence in transplant rejection episodes.
van Son WJ; van der Woude FJ; van der Hem GK; The TH; Ockhuizen T; Tegzess AM
Transplantation; 1985 May; 39(5):510-4. PubMed ID: 2986326
[TBL] [Abstract][Full Text] [Related]
4. Complement components in kidney allograft recipients: relationship to cytomegalovirus infection.
Chatterjee S; Fiala M; Arroyave C; Azen S; Cosgrove D
J Med Virol; 1982; 9(3):237-44. PubMed ID: 6284872
[TBL] [Abstract][Full Text] [Related]
5. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
6. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
[TBL] [Abstract][Full Text] [Related]
7. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
Corvetta A; Spaeth PJ; Ghirelli PA; Orecchioni F; Buetler R; Montroni M; Nydegger UE
Diagn Immunol; 1983; 1(4):315-23. PubMed ID: 6333960
[TBL] [Abstract][Full Text] [Related]
8. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
9. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes and complement breakdown product C3d in glomerulonephritis and kidney transplantation.
Sølling J
Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):213-20. PubMed ID: 6391086
[TBL] [Abstract][Full Text] [Related]
11. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
12. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
14. Activation of the complement system in primary sclerosing cholangitis.
Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
[TBL] [Abstract][Full Text] [Related]
15. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.
Swaak AJ; Hannema A; Vogelaar C; Boom FA; van Es L; van Aalst R; Statius van Eps LW
Rheumatol Int; 1982; 2(4):161-6. PubMed ID: 6984977
[TBL] [Abstract][Full Text] [Related]
16. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
17. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and increased alveolar-capillary permeability after major surgery and in adult respiratory distress syndrome.
Hällgren R; Samuelsson T; Modig J
Crit Care Med; 1987 Mar; 15(3):189-93. PubMed ID: 3816249
[TBL] [Abstract][Full Text] [Related]
19. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and HLA-B27.
Meri S; Partanen J; Leirisalo-Repo M; Repo H
Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
